This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Latest papers
A Population-Based Study of Care at the End of Life Among People With HIV in Ontario From 2010 to 2013.
Journal of acquired immune deficiency syndromes (1999) · 2017
Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials.
HIV clinical trials · 2016
IAS Towards an HIV Cure Symposium: people focused, science driven: 18-19 July 2015, Vancouver, Canada.
Journal of virus eradication · 2015
Latest funding
- $688,500
CEACAM-1 and TIM-3 interactions in HIV reservoir establishment, persistence and evasion from HIV specific immunity.
CIHR · 2017 · Co-investigator
- $250,000
Developing a Novel Modular Nanoparticle Vaccine Strategy to Induce Durable Systemic and Mucosal HIV Envelope Specific Antibodies
CIHR · 2017 · Principal investigator
- $109,216
Immuno-modulatory HIV-1 nanoparticles as a novel vaccine platform
CIHR · 2016 · Co-investigator
3 publications.
A Population-Based Study of Care at the End of Life Among People With HIV in Ontario From 2010 to 2013.
Kendall CE, Chalifoux M, Manuel D, Reinhard R, Robinson G, Bacon J, Rourke SB, Rosenes R, Tanuseputro P
Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials.
Kim CJ, Walmsley SL, Raboud JM, Kovacs C, Coburn B, Rousseau R, Reinhard R, Rosenes R, Kaul R
IAS Towards an HIV Cure Symposium: people focused, science driven: 18-19 July 2015, Vancouver, Canada.
Fidler S, Thornhill J, Malatinkova E, Reinhard R, Lamplough R, Ananworanich J, Chahroudi A
CEACAM-1 and TIM-3 interactions in HIV reservoir establishment, persistence and evasion from HIV specific immunity.
Principal investigators: Ostrowski, Mario A
Keywords: Cd4 Cells; Ceacam-1; Ctl; Cytotoxic T Cell; Hiv; Hiv Cure Research; Immune Exhaustion; Immunotherapy; Latency; Tim-3
Developing a Novel Modular Nanoparticle Vaccine Strategy to Induce Durable Systemic and Mucosal HIV Envelope Specific Antibodies
Principal investigators: Ostrowski, Mario A; Reinhard, Robert J
Keywords: Antibodies; B Cells; Hiv Vaccines; Nanoparticles
Immuno-modulatory HIV-1 nanoparticles as a novel vaccine platform
Principal investigators: Julien, Jean-Philippe
Keywords: Adjuvants; B Cell Activation; Broadly Neutralizing Antibodies; Hiv-1 Vaccine; Immunogen Design; Nanotechnology
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Infectious Diseases
- Cell and Systems Biology
- Psychosocial Oncology and Palliative Care
- Department of Medicine
- Family Medicine
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Ron Rosenes
Infectious Diseases
2 shared papers, latest 2017
Ron Rosenes
Family Medicine
1 shared papers, latest 2017
Peter Tanuseputro
Psychosocial Oncology and Palliative Care
1 shared papers, latest 2017
Rupert Kaul
Medicine
1 shared papers, latest 2016
Bryan Coburn
Cell and Systems Biology
1 shared papers, latest 2016
Peter Tanuseputro
Department of Medicine
1 shared papers, latest 2017
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.